Need Help? Chat Now With a Live Representative!

White Papers

Optimizing Oncology Clinical Development Programs Via Risk-Based Quality Management (RBQM)

Optimizing Oncology Clinical Development Programs Via Risk-Based Quality Management (RBQM)

White Paper Risk-Based Quality Management Technology-Driven CRO: Optimizing Oncology Clinical Development Programs Via Risk-Based Quality Management (RBQM) There are currently […]

March 31, 2023
Optimizing Oncology Trials via Remote Monitoring

Optimizing Oncology Trials via Remote Monitoring

White Paper OPTIMIZING ONCOLOGY TRIALS via Remote Monitoring Within the oncology drug development pipeline, which has increased by over 60% […]

March 31, 2023
Critical Considerations for Rare & Orphan Disease Trial Planning

Critical Considerations for Rare & Orphan Disease Trial Planning

Critical Characteristics in Identifying a Rare Disease CRO Partner A Question-First Approach to Operationalizing Rare Disease Studies This Atlantic Research […]

March 31, 2021
Rare Perspectives: Factor X Deficiency

Rare Perspectives: Factor X Deficiency

Factor X Deficiency Keys To Clinical Trial Success In Rare Disease Indications This Atlantic Research Group rare disease case study […]

March 31, 2020
Patient Centricity in a Consumer Model

Patient Centricity in a Consumer Model

White Paper: Patient Centricity in a Consumer Model This Atlantic Research Group rare disease white paper is available for download […]

March 31, 2019
GO TO TOP